| Item Type | Name |
|
Concept
|
Treatment Outcome
|
|
Academic Article
|
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
|
|
Academic Article
|
Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.
|
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
|
|
Academic Article
|
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
|
|
Academic Article
|
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
|
|
Academic Article
|
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
|
|
Academic Article
|
A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
|
|
Academic Article
|
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
|
|
Academic Article
|
Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial.
|
|
Academic Article
|
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
|
|
Academic Article
|
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
|
|
Academic Article
|
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
|
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
|
Academic Article
|
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
|
Academic Article
|
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.
|
|
Academic Article
|
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
|
|
Academic Article
|
Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
|
|
Academic Article
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
|
Academic Article
|
Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
|
|
Academic Article
|
Inhaled human insulin: an inspiration for patients with diabetes mellitus?
|
|
Academic Article
|
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
|
|
Academic Article
|
Lipid-lowering effects of statins: a comparative review.
|
|
Academic Article
|
Differences between clinical trial efficacy and real-world effectiveness.
|
|
Academic Article
|
High-density lipoprotein metabolism: potential therapeutic targets.
|
|
Academic Article
|
Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals.
|
|
Academic Article
|
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
|
|
Academic Article
|
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
|
|
Academic Article
|
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
|
|
Academic Article
|
Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
|
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
|
Academic Article
|
The editor's roundtable: the JUPITER trial--initial results and clinical implications.
|
|
Academic Article
|
Management of dyslipidemia in patients with complicated metabolic syndrome.
|
|
Academic Article
|
Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.
|
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
|
Academic Article
|
Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.
|
|
Academic Article
|
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
|
|
Academic Article
|
Statin and ezetimibe combination therapy in cardiovascular disease.
|
|
Academic Article
|
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
|
|
Academic Article
|
An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time.
|
|
Academic Article
|
One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
|
|
Academic Article
|
Retrospective comparison of the effectiveness of a fenofibrate 145 mg formulation compared with the standard 160 mg tablet.
|
|
Academic Article
|
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
|
|
Academic Article
|
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
|
|
Academic Article
|
Cholesterol absorption blockade with ezetimibe.
|
|
Academic Article
|
Peripheral artery disease, biomarkers, and darapladib.
|
|
Academic Article
|
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist.
|
|
Academic Article
|
Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
|
|
Academic Article
|
Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
|
|
Academic Article
|
Apolipoprotein A-I therapy promise, challenges, and disappointment.
|
|
Academic Article
|
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
|
|
Academic Article
|
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
|
|
Academic Article
|
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.
|
|
Academic Article
|
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
|
|
Academic Article
|
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
|
|
Academic Article
|
Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.
|
|
Academic Article
|
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
|
|
Academic Article
|
Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
|
|
Academic Article
|
Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.
|
|
Academic Article
|
Analysis of Minnesota Multiphasic Personality Inventory-2 profiles of prospective anonymous oocyte donors in relation to the outcome of the donor selection process.
|
|
Academic Article
|
Limitations of controlled augmentation trials in schizophrenia.
|
|
Academic Article
|
Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
|
|
Academic Article
|
Premorbid functioning and treatment response in recent-onset schizophrenia.
|
|
Academic Article
|
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
|
|
Academic Article
|
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
|
|
Academic Article
|
Efficacy of the National Cholesterol Education Program Step I diet. A randomized trial incorporating quick-service foods.
|
|
Academic Article
|
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
|
|
Academic Article
|
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
|
|
Academic Article
|
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
|
|
Academic Article
|
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
|
|
Academic Article
|
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.
|
|
Academic Article
|
Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review.
|
|
Academic Article
|
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes.
|
|
Academic Article
|
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
|
|
Academic Article
|
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
|
|
Academic Article
|
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction.
|
|
Academic Article
|
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
|
|
Academic Article
|
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old.
|
|
Academic Article
|
Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
|
|
Academic Article
|
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
|
|
Academic Article
|
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
|
|
Academic Article
|
Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice.
|
|
Academic Article
|
Changing characteristics of statin-related cIMT trials from 1988 to 2006.
|
|
Academic Article
|
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
|
|
Academic Article
|
Intensive statin therapy in India: Demonstrating efficacy and safety.
|
|
Academic Article
|
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
|
|
Academic Article
|
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
|
|
Academic Article
|
Long-term safety of risperidone.
|
|
Academic Article
|
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?
|
|
Academic Article
|
Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma.
|
|
Academic Article
|
Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
|
|
Academic Article
|
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
|
|
Academic Article
|
Pneumococcal endocarditis in Alaska natives. A population-based experience, 1978 through 1990.
|
|
Academic Article
|
Can We Cure Atherosclerosis?
|
|
Academic Article
|
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
|
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
|
Academic Article
|
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
|
|
Academic Article
|
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
|
|
Academic Article
|
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial.
|
|
Academic Article
|
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
|
|
Academic Article
|
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
|
|
Academic Article
|
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
|
|
Academic Article
|
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials.
|
|
Academic Article
|
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
|
|
Academic Article
|
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
|
|
Academic Article
|
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials.
|
|
Academic Article
|
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
|
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|